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CASE REPORT
Fig. 1. 1.3×1.2 cm-sized itchy, errythematous, lobulated nodule
with a partially crusted surface on the left calf area.
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Syringocystadenoma papilliferum (SCAP) occurs singly or in 
association with other tumors. Although it is rare, the 
association of tubular apocrine adenoma (TAA) with SCAP in 
the background of nevus sebaceous (NS) on the scalp is well 
documented. However, the co-existence of these two tumors 
without background of NS has not been reported on the 
extremities. We report a case of SCAP associated with TAA 
on the calf without pre-existing NS in an adult. (Ann 
Dermatol 23(S2) S175∼S178, 2011)
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INTRODUCTION
Syringocystadenoma papilliferum (SCAP) is a benign ad-
nexal tumor, thought to arise from either pleuripotential 
appendageal cells or apo-eccrine glands
1,2. It may occur 
de novo in children but frequently arises from a head or 
neck organoid nevus
3. It is rarely found on the trunk or 
limbs and occasionally coexists with other tumors. 
Recently, SCAP associated with tubular apocrine adenoma 
(TAA) in the background of nevus sebaceous (NS) on the 
scalp and facial area has been reported
2-10. However, the 
co-existence of these two tumors without background of 
NS on a non-scalp area has rarely been reported. Herein, 
we report an unusual case of SCAP associated with TAA 
on the calf area without pre-existing NS, which occurred 
de novo in an adult. 
CASE REPORT
A 59-year-old male presented with a 10-year history of a 
leg nodule, which had increased in size recently. Physical 
examination revealed a 1.3×1.2 cm sized itchy, eryth-
ematous and lobulated nodule on the left calf. There were 
erythematous and slightly depressed crusted lesions on 
the surface area (Fig. 1). The lesion was completely 
excised. Upon microscopic examination, the superficial 
component was characterized by cystic invaginations of 
infundibular epithelium, lined by two layers of glandular 
epithelium (tall columnar luminar cells and cuboidal basa-JH Yoon, et al
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Fig. 4. Findings of the lower part of the lesion. Variable sized tubular structures are seen. Amorphous material containing cellular
fragments was observed in several lumina (H&E, A: ×40, B: ×100).
Fig. 3. Findings of the upper section of the lesion. Cystic invagination lined by glandular epithelium with papillary projections. The
cystic invagination is connected to the skin surface through the infundibular epithelium (H&E, A: ×40, B: ×100).
Fig. 2. Whole-mounted view of the lesion: Tumor is composed
of two histologically distinct parts. The upper part shows 
syringocystadenoma papilliferum and the lower part shows 
tubular apocrine adenoma (H&E, scanning view).
loid basal cells), with papillary projections. The glandular 
epithelium had areas of decapitation secretion (Fig. 2).
The epidermis overlying the tumor showed crateriform 
squamous cell lesions with mild nuclear atypia and focal 
dyskeratosis. Around this crateriform lesion, irregular in-
vasion of the dermis by uneven, jagged, blunt ended epi-
dermal cell masses and strands was observed (Fig. 3). 
Immunohistochemical stains taken for this lesion revealed 
all negatives for p53, p63, and Ki-67. The deeper portion 
had variable sized tubular structures, surrounded by in-
creased collagenous stroma. The tubules usually con-
tained two layers of epithelial cells; the outer layer had 
flattened cells, and the inner layer had columnar cells 
with decapitation secretion (Fig. 4). The findings in the up-
per level of the lesion were interpreted as SCAP and those 
in the deeper level were TAA. Syringocystadenoma Papilliferum in Co-existence with Tubular Apocrine Adenoma of the Calf
Vol. 23, Suppl. 2, 2011 S177
Table 1. Cases reported as tubular apocrine adenoma with 
syringocystadenoma papilliferum on unusual sites
Case Sex/Age 
(years) Site Association 
with NS
Lee et al. (2005)
9 F/74 EAC Absent
Yamane et al. (2007)
17 F/77 Breast Present
NS: nevus sebaceous, F: female, EAC: external auditory canal.
DISCUSSION
SCAP has been reported to arise frequently in association 
with NS or basal cell epithelioma
3. However, it occasion-
ally coexists with other tumors originating from skin ap-
pendageal cells. In a study of 126 SCAP cases, Fujita and 
Kobayashi reported that SCAP was most frequently asso-
ciated with sebaceous nevus (40 cases), followed by basal 
cell epithelioma (13 cases), sebaceous epithelioma (4 cas-
es), apocrine hydrocystadenoma (4 cases), trichoepithelio-
ma (2 cases), and eccrine spiroadenoma (1 case)
11. 
The association of SCAP with TAA was firstly reported in 
1979 by Civatte et al.
4. Since then, several similar cases 
have been described in the literature with common fea-
tures of occurrence on the scalp and associated with 
NS
4-10. Fisher
12 described TAA as a minor variant of SCAP 
due to a clinicopathological similarity. However, Umbert 
and Winkelmann
13 suggested that TAA is an independent 
clinical entity, consisting of a benign appendage tumor of 
apocrine origin, associated with organoid nevus. 
TAA and SCAP may show histopathological overlaps, with 
some lesions having features of both neoplasms (SCAP+ 
TAA). Kazakov et al.
14 confirmed a morphological overlap 
between TAA and SCAP and demonstrateed a lack of uni-
versally accepted diagnostic criteria even among experi-
enced dermatopathologists and pathologists. In this study, 
interobserver variability occurred when there were epi-
dermal acanthosis, papillomatosis, and connections of 
neoplastic tubules to the overlying epidermis and/or fol-
licular infundibula as well as plasma cell infiltration. 
These features accounted for the morphological overlap 
between TAA and SCAP.
Furthermore, SCAP is considered a hamartoma that re-
capitulates the formation of the folliculo-apocrine unit
14. 
In this regard, TAA is interpreted as a deeper dermal tubu-
lar component of SCAP, rather than a combination of TAA 
with hamartoma
15,16.
Cribier et al.
2 reported that SCAP is the most common be-
nign secondary tumor associated with NS. This is prob-
ably due to the presence of ectopic apocrine glands that 
are located in the deepest part of the NS, which can lead 
to either apocrine cysts or to SCAP. Thus, it is commonly 
located on the face and scalp. However, in our case there 
was no evidence of pre-existing NS upon microscopic 
examination. Only 2 cases of TAA associated with SCAP 
without NS of the scalp have been reported in the medical 
literature, and these cases are summarized in Table 1.
Our case demonstrates that SCAP with TAA can arise on 
non-scalp areas without a NS background in adults. 
Although the origin of SCAP and TAA and their relation-
ships with follicular units need to be evaluated, we sug-
gest that there can be SCAP lesions with TAA as a deeper 
component presenting on unusual sites.
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